Profile data is unavailable for this security.
About the company
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.
- Revenue in CNY (TTM)355.15m
- Net income in CNY-92.02m
- Incorporated1993
- Employees463.00
- LocationBeihai Gofar Chuanshan Biological Co LtdNo. 3, Beibuwan Middle RoadBEIHAI 536000ChinaCHN
- Phone+86 7 793200619
- Fax+86 7 793200618
- Websitehttp://www.gofar.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Kai Kai Industrial Co Ltd | 959.84m | 52.77m | 2.00bn | 492.00 | 49.09 | 4.18 | -- | 2.08 | 0.2172 | 0.2172 | 3.95 | 2.55 | 0.7819 | 10.68 | 3.50 | 1,950,902.00 | 4.49 | 2.39 | 6.98 | 3.53 | 18.63 | 23.54 | 5.74 | 3.20 | 1.28 | -- | 0.0355 | 26.33 | 3.46 | 1.06 | -1.57 | 2.21 | 34.01 | 1.72 |
| Beihai Gofar Chuanshan Biological Co Ltd | 355.15m | -92.02m | 2.47bn | 463.00 | -- | 2.88 | -- | 6.95 | -0.1755 | -0.1755 | 0.6775 | 1.63 | 0.3258 | 3.17 | 1.49 | 767,059.10 | -8.32 | -0.517 | -9.99 | -0.6208 | 22.89 | 24.59 | -25.54 | -1.44 | 2.60 | -63.64 | 0.0336 | -- | -19.69 | 10.46 | -336.10 | -- | -17.59 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.25bn | 136.43m | 2.81bn | 1.30k | 20.64 | 2.03 | -- | 1.25 | 0.4767 | 0.4767 | 7.86 | 4.86 | 0.813 | 3.96 | 4.60 | 1,736,789.00 | 5.54 | 5.93 | 10.82 | 11.25 | 47.56 | 53.26 | 6.81 | 7.82 | 0.8523 | 7.35 | 0.3362 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Shanghai New World Co Ltd | 1.15bn | 33.59m | 4.05bn | 1.20k | 120.57 | 0.9633 | -- | 3.54 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Holder | Shares | % Held |
|---|---|---|
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2023 | 693.80k | 0.15% |
| Gfund Management Co., Ltd.as of 30 Jun 2023 | 409.40k | 0.09% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2023 | 137.90k | 0.03% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 83.40k | 0.02% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2022 | 14.90k | 0.00% |
| Sealand Securities Co., Ltd. (Investment Management)as of 30 Jun 2023 | 5.20k | 0.00% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2023 | 400.00 | 0.00% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Bohai Huijin Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
